<p>(TheNewswire)</p>
<p>加拿大不列颠哥伦比亚省温哥华</p>
<p>–2026 年 4 月 1 日– TheNewswire - MindBio</p>
<p>Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6);</p>
<p>(OTCQB:MBQIF)（以下简称 “公司” 或</p>
<p>“MindBio”），是一家生物技术公司，正在商业化</p>
<p>用于药物和酒精中毒检测的预测技术，</p>
<p>采用语音分析和人工智能，现高兴地</p>
<p>宣布已完成之前宣布的增资</p>
<p>非承销私人配售（以下简称 “发行”），</p>
<p>总收益为 1,437,828.87 美元。</p>
<p>根据该发行，公司发行了</p>
<p>总计 2,396,381 个单位（每个单位称为 “单位”），</p>
<p>每个单位的价格为 0.60 美元，总收益为 1,437,828.87 美元。每个单位</p>
<p>由一股公司普通股（每股称为 “股份”）和一份</p>
<p>股份购买权证（每份称为 “权证”）组成。每份</p>
<p>权证使持有人有权在发行结束后 36 个月内以</p>
<p>0.80 美元的价格购买额外股份，</p>
<p>在加拿大证券交易所（以下简称 “CSE”）的股份收盘价</p>
<p>在连续十个交易日内超过 1.00 美元的情况下，权证将提前到期。</p>
<p>公司计划将发行的净收益用于加速开发和部署一项专有</p>
<p>硬件和边缘技术，以便在矿区远程和可扩展地</p>
<p>使用 MindBio 的中毒检测解决方案，</p>
<p>用于招聘专业人员和一般营运资金。</p>
<p>与发行完成相关，公司支付了总计</p>
<p>70,183.97 美元的现金费用，并向合格的第三方</p>
<p>发行了总计 116,973 份不可转让的股份购买权证（每份称为 “寻找者权证”），</p>
<p>这些第三方向公司介绍了认购者。每份寻找者权证使持有人有权</p>
<p>在发行日期后 36 个月内以 0.80 美元的价格购买一股，</p>
<p>在 CSE 的股份收盘价在连续十个交易日内超过 1.00 美元的情况下，权证将提前到期。</p>
<p>与发行相关的所有证券</p>
<p>在适用证券法的规定下，需遵守为期</p>
<p>四个月零一天的转售限制。</p>
<p>该发行仍需最终监管批准。</p>
<p>推广和沟通</p>
<p>合作</p>
<p>MindBio 还宣布已与两家独立服务提供商签订</p>
<p>协议，为公司提供推广、沟通、市场营销和广告服务。</p>
<p>公司已与 Stockouse Publishing Ltd（以 The Market Link 名义运营）</p>
<p>根据广告活动协议进行合作，并与 Investor Brand Network（“IBN”）</p>
<p>根据联合传播协议进行合作。这些合作的目的是</p>
<p>提高公众对公司的认识，并扩大公司新闻和信息的传播。两项</p>
<p>合作均不包括市场做市服务，且在任何一项</p>
<p>合作中不会发行公司的证券作为补偿。公司确认，The Market Link 和 IBN 均为</p>
<p>与公司没有直接或间接利益关系的独立方。根据公司所知，</p>
<p>The Market Link 和 IBN 均对公司或其证券没有任何直接或间接的</p>
<p>利益。</p>
<p>The Market Link 的合作于 2026 年 3 月 24 日开始，</p>
<p>将持续到 2027 年 3 月 24 日。在合作期间，指定的客户经理将支持</p>
<p>活动规划、执行和优化。服务包括访问</p>
<p>上市平台的发行人广告库存、客户经理的战略支持、活动执行和</p>
<p>绩效报告。推广活动将通过 The Market Link 选择的出版商和投资者平台进行。The Market Link</p>
<p>将在公司私人配售结束时一次性获得 36,750 美元的现金补偿。</p>
<p>在合作中不会授予股票期权或其他基于证券的补偿。</p>
<p>The Market Link 的联系信息如下：</p>
<p>Stockouse Publishing Ltd dba The Market Link</p>
<p>1130 - 1055 West Hastings St.</p>
<p>温哥华， BC V6E 2E9</p>
<p>电子邮件：info@themarketlink.com</p>
<p>电话：1-778-588-7012</p>
<p>IBN 的合作于 2026 年 3 月 25 日开始，</p>
<p>IBN 的联系信息如下：</p>
<p>Investor Brand Network</p>
<p>1108 Lavaca Street, Suite 110-IBN</p>
<p>奥斯丁， TX 78701</p>
<p>联系人：Dutch DeWaard</p>
<p>电子邮件：Dutch@IBN.fm</p>
<p>总办公室电话：（512）354-7000</p>
<p>联系人电话：480-734-5834</p>
<p>如需更多信息，请联系：</p>
<p>Justin Hanka, 首席执行官</p>
<p>+61 433140886</p>
<p>justin@mindbiotherapeutics.com</p>
<p>www.mindbiotherapeutics.com</p>
<p>关于 MindBio Therapeutics Corp.</p>
<p>MindBio 是一家生物技术公司，正在商业化用于通过声音分析检测药物和酒精中毒的人工智能预测技术。该人工智能预测模型利用超过 5000 万个数据点，仅通过人声就能以显著的准确性预测酒精中毒。公司目前正在收集数据，以使其预测工具能够在消费者和企业环境中用于其他类型的中毒检测。</p>
<p>关于前瞻性声明的警示说明：</p>
<p>本新闻稿包含适用证券法意义上的 “前瞻性声明”，包括但不限于关于本次发行收益的预期用途的声明，包括使用声音和人工智能开发公司的企业平台以检测药物和酒精中毒，以及公司与市场链接和投资者品牌网络的合作的预期持续时间、范围和预期收益。前瞻性声明可以通过以下词语识别：“预期”、“打算”、“计划”、“预算”、“相信”、“项目”、“估计”、“期望”、“安排”、“预测”、“战略”、“未来”、“可能”、“可能会”、“将要”、“可以”、“会”、“应该”、“将” 和类似的对未来时期的引用或否定或可比术语，以及通常用于未来和条件的术语。前瞻性声明基于提供时的假设。然而，不能保证这些假设会反映这些项目或因素的实际结果。</p>
<p>此外，存在已知和未知的风险因素，可能导致公司的实际结果和财务状况与前瞻性声明中所指示的显著不同。因此，您不应依赖这些前瞻性声明。可能导致实际结果和财务状况与前瞻性声明中所指示的显著不同的重要风险因素包括但不限于：未能获得最终监管批准；企业平台开发或部署中的技术挑战；加拿大和澳大利亚的一般经济、市场和商业状况；市场波动；以及任何本新闻稿中描述的交易或事件的时间表中不可预见的延误。所有前瞻性信息均完全受此警示声明的限制。</p>
<p>公司不承担修订或更新任何此类前瞻性声明的义务，也不承担公开宣布任何修订结果以反映未来结果、事件或发展的义务，除非法律要求。</p>
<p>加拿大证券交易所及其监管服务提供者（根据加拿大证券交易所政策定义的术语）对本发布的充分性或准确性不承担任何责任。</p>
<p>版权 (c) 2026 TheNewswire - 保留所有权利。</p>

NBSE.ESC

BTMD

医药突破 ETF - ALPS

<p>MindBio Therapeutics Corp. 成功完成了一项私人配售，筹集资金 1,437,828.87 美元，发行了 2,396,381 个单位，每个单位价格为 0.60 美元。这笔资金将用于增强其醉酒检测技术的开发。此外，公司还聘请了两家服务提供商进行推广和营销服务，以提高公众意识和投资者覆盖面。这些合作包括现金补偿，并将持续一年。所有发行的证券在四个月内受限于转售，并待最终监管批准</p>

<p>(TheNewswire)</p>
<div class="lb-trans"><p>(TheNewswire)</p>
</div><p>Vancouver, British Columbia</p>
<div class="lb-trans"><p>加拿大不列颠哥伦比亚省温哥华</p>
</div><p>– April 1, 2026 – TheNewswire - MindBio</p>
<div class="lb-trans"><p>–2026 年 4 月 1 日– TheNewswire - MindBio</p>
</div><p>Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6);</p>
<div class="lb-trans"><p>Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6);</p>
</div><p>(OTCQB:MBQIF) (the “Company” or</p>
<div class="lb-trans"><p>(OTCQB:MBQIF)（以下简称 “公司” 或</p>
</div><p>“MindBio”), a biotechnology company that is commercialising</p>
<div class="lb-trans"><p>“MindBio”），是一家生物技术公司，正在商业化</p>
</div><p>prediction technologies for drug and alcohol intoxication detection</p>
<div class="lb-trans"><p>用于药物和酒精中毒检测的预测技术，</p>
</div><p>using speech analytics and artificial intelligence, is pleased to</p>
<div class="lb-trans"><p>采用语音分析和人工智能，现高兴地</p>
</div><p>announce that it has closed its previously announced upsized</p>
<div class="lb-trans"><p>宣布已完成之前宣布的增资</p>
</div><p>non-brokered private placement (the “Offering”) for</p>
<div class="lb-trans"><p>非承销私人配售（以下简称 “发行”），</p>
</div><p>gross proceeds of $1,437,828.87</p>
<div class="lb-trans"><p>总收益为 1,437,828.87 美元。</p>
</div><p>Pursuant to the Offering, the Company issued an</p>
<div class="lb-trans"><p>根据该发行，公司发行了</p>
</div><p>aggregate of 2,396,381 units (each, a “Unit”) at a price</p>
<div class="lb-trans"><p>总计 2,396,381 个单位（每个单位称为 “单位”），</p>
</div><p>of $0.60 per Unit for gross proceeds of $1,437,828.87. Each Unit</p>
<div class="lb-trans"><p>每个单位的价格为 0.60 美元，总收益为 1,437,828.87 美元。每个单位</p>
</div><p>consists of one common share of the Company (each, a “Share”) and one</p>
<div class="lb-trans"><p>由一股公司普通股（每股称为 “股份”）和一份</p>
</div><p>Share purchase warrant (each, a “Warrant”). Each</p>
<div class="lb-trans"><p>股份购买权证（每份称为 “权证”）组成。每份</p>
</div><p>Warrant entitles the holder to acquire an additional Share at a price</p>
<div class="lb-trans"><p>权证使持有人有权在发行结束后 36 个月内以</p>
</div><p>of $0.80 for a period of thirty-six months following closing of the</p>
<div class="lb-trans"><p>0.80 美元的价格购买额外股份，</p>
</div><p>Offering, subject to accelerated expiry in the event the closing price</p>
<div class="lb-trans"><p>在加拿大证券交易所（以下简称 “CSE”）的股份收盘价</p>
</div><p>of the Shares on the Canadian Securities Exchange (the “CSE”) exceeds $1.00</p>
<div class="lb-trans"><p>在连续十个交易日内超过 1.00 美元的情况下，权证将提前到期。</p>
</div><p>for ten consecutive trading days.</p>
<div class="lb-trans"><p>公司计划将发行的净收益用于加速开发和部署一项专有</p>
</div><p>The Company intends to use the net proceeds from the</p>
<div class="lb-trans"><p>硬件和边缘技术，以便在矿区远程和可扩展地</p>
</div><p>Offering to accelerate the development and deployment of a proprietary</p>
<div class="lb-trans"><p>使用 MindBio 的中毒检测解决方案，</p>
</div><p>hardware and edge technology which will enable the remote and scalable</p>
<div class="lb-trans"><p>用于招聘专业人员和一般营运资金。</p>
</div><p>use of MindBio’s intoxication detection solution at mining sites,</p>
<div class="lb-trans"><p>与发行完成相关，公司支付了总计</p>
</div><p>for recruitment of specialised personnel and for general working</p>
<div class="lb-trans"><p>70,183.97 美元的现金费用，并向合格的第三方</p>
</div><p>capital purposes.</p>
<div class="lb-trans"><p>发行了总计 116,973 份不可转让的股份购买权证（每份称为 “寻找者权证”），</p>
</div><p>In connection with completion of the Offering, the</p>
<div class="lb-trans"><p>这些第三方向公司介绍了认购者。每份寻找者权证使持有人有权</p>
</div><p>Company paid aggregate cash fees of $70,183.97 and issued an aggregate</p>
<div class="lb-trans"><p>在发行日期后 36 个月内以 0.80 美元的价格购买一股，</p>
</div><p>of 116,973 non-transferable Share purchase warrants (each, a</p>
<div class="lb-trans"><p>在 CSE 的股份收盘价在连续十个交易日内超过 1.00 美元的情况下，权证将提前到期。</p>
</div><p>“Finder Warrant”) to eligible third-parties who introduced subscribers to</p>
<div class="lb-trans"><p>与发行相关的所有证券</p>
</div><p>the Offering. Each Finder Warrant entitles the holder thereof to</p>
<div class="lb-trans"><p>在适用证券法的规定下，需遵守为期</p>
</div><p>acquire one Share at a price of $0.80 for a period of thirty-six</p>
<div class="lb-trans"><p>四个月零一天的转售限制。</p>
</div><p>months after the date of issue, subject to accelerated expiry in the</p>
<div class="lb-trans"><p>该发行仍需最终监管批准。</p>
</div><p>event the closing price of the Shares on the CSE exceeds $1.00 for ten</p>
<div class="lb-trans"><p>推广和沟通</p>
</div><p>consecutive trading days.</p>
<div class="lb-trans"><p>合作</p>
</div><p>All securities issued in connection with the Offering</p>
<div class="lb-trans"><p>MindBio 还宣布已与两家独立服务提供商签订</p>
</div><p>are subject to restrictions on resale for a period of</p>
<div class="lb-trans"><p>协议，为公司提供推广、沟通、市场营销和广告服务。</p>
</div><p>four-months-and-one-day in accordance with applicable securities laws.</p>
<div class="lb-trans"><p>公司已与 Stockouse Publishing Ltd（以 The Market Link 名义运营）</p>
</div><p>The Offering remains subject to final regulatory approvals.</p>
<div class="lb-trans"><p>根据广告活动协议进行合作，并与 Investor Brand Network（“IBN”）</p>
</div><p>Promotional and Communications</p>
<div class="lb-trans"><p>根据联合传播协议进行合作。这些合作的目的是</p>
</div><p>Engagements</p>
<div class="lb-trans"><p>提高公众对公司的认识，并扩大公司新闻和信息的传播。两项</p>
</div><p>MindBio also announces that it has entered into</p>
<div class="lb-trans"><p>合作均不包括市场做市服务，且在任何一项</p>
</div><p>agreements with two arm’s length service providers to provide</p>
<div class="lb-trans"><p>合作中不会发行公司的证券作为补偿。公司确认，The Market Link 和 IBN 均为</p>
</div><p>promotional, communications, marketing and advertising services to the</p>
<div class="lb-trans"><p>与公司没有直接或间接利益关系的独立方。根据公司所知，</p>
</div><p>Company.</p>
<div class="lb-trans"><p>The Market Link 和 IBN 均对公司或其证券没有任何直接或间接的</p>
</div><p>The Company has engaged Stockouse Publishing Ltd dba</p>
<div class="lb-trans"><p>利益。</p>
</div><p>The Market Link (“The Market</p>
<div class="lb-trans"><p>The Market Link 的合作于 2026 年 3 月 24 日开始，</p>
</div><p>Link”) pursuant to an advertising campaign</p>
<div class="lb-trans"><p>将持续到 2027 年 3 月 24 日。在合作期间，指定的客户经理将支持</p>
</div><p>agreement and Investor Brand Network (“IBN”) pursuant to a</p>
<div class="lb-trans"><p>活动规划、执行和优化。服务包括访问</p>
</div><p>syndicated communications agreement. The purpose of these engagements</p>
<div class="lb-trans"><p>上市平台的发行人广告库存、客户经理的战略支持、活动执行和</p>
</div><p>is to increase public awareness of the Company and broaden</p>
<div class="lb-trans"><p>绩效报告。推广活动将通过 The Market Link 选择的出版商和投资者平台进行。The Market Link</p>
</div><p>dissemination of the Company’s news and information. Neither</p>
<div class="lb-trans"><p>将在公司私人配售结束时一次性获得 36,750 美元的现金补偿。</p>
</div><p>engagement includes market making services, and no securities of the</p>
<div class="lb-trans"><p>在合作中不会授予股票期权或其他基于证券的补偿。</p>
</div><p>Company will be issued as compensation in connection with either</p>
<div class="lb-trans"><p>The Market Link 的联系信息如下：</p>
</div><p>engagement. The Company confirms that both The Market Link and IBN are</p>
<div class="lb-trans"><p>Stockouse Publishing Ltd dba The Market Link</p>
</div><p>arm’s length parties to the Company. To the knowledge of the</p>
<div class="lb-trans"><p>1130 - 1055 West Hastings St.</p>
</div><p>Company, neither The Market Link nor IBN has any direct or indirect</p>
<div class="lb-trans"><p>温哥华， BC V6E 2E9</p>
</div><p>interest in the Company or its securities.</p>
<div class="lb-trans"><p>电子邮件：info@themarketlink.com</p>
</div><p>The Market Link engagement commenced on March 24, 2026</p>
<div class="lb-trans"><p>电话：1-778-588-7012</p>
</div><p>and will continue until March 24, 2027. Under the engagement, an</p>
<div class="lb-trans"><p>IBN 的合作于 2026 年 3 月 25 日开始，</p>
</div><p>assigned account manager will support campaign planning, execution and</p>
<div class="lb-trans"><p>IBN 的联系信息如下：</p>
</div><p>optimization throughout the program term. Services include access to</p>
<div class="lb-trans"><p>Investor Brand Network</p>
</div><p>issuer advertising inventory across listed platforms, strategic</p>
<div class="lb-trans"><p>1108 Lavaca Street, Suite 110-IBN</p>
</div><p>support from an account manager, campaign execution, and performance</p>
<div class="lb-trans"><p>奥斯丁， TX 78701</p>
</div><p>reporting. The promotional activity will occur through The Market</p>
<div class="lb-trans"><p>联系人：Dutch DeWaard</p>
</div><p>Link’s selected publishers and investor platforms. The Market Link</p>
<div class="lb-trans"><p>电子邮件：Dutch@IBN.fm</p>
</div><p>will receive cash compensation of $36,750 payable upfront upon closing</p>
<div class="lb-trans"><p>总办公室电话：（512）354-7000</p>
</div><p>of the Company’s private placement. No stock</p>
<div class="lb-trans"><p>联系人电话：480-734-5834</p>
</div><p>options or other securities-based compensation will be granted in</p>
<div class="lb-trans"><p>如需更多信息，请联系：</p>
</div><p>connection with the engagement.</p>
<div class="lb-trans"><p>Justin Hanka, 首席执行官</p>
</div><p>The Market Link contact details are as follows:</p>
<div class="lb-trans"><p>+61 433140886</p>
</div><p>Stockouse Publishing Ltd dba The Market Link</p>
<div class="lb-trans"><p>justin@mindbiotherapeutics.com</p>
</div><p>1130 - 1055 West Hastings St.</p>
<div class="lb-trans"><p>www.mindbiotherapeutics.com</p>
</div><p>Vancouver, BC V6E 2E9</p>
<div class="lb-trans"><p>关于 MindBio Therapeutics Corp.</p>
</div><p>Email: info@themarketlink.com</p>
<p>Telephone: 1-778-588-7012</p>
<p>The IBN engagement commenced on March 25, 2026 and willcontinue until March 25, 2027. Under the engagement, IBN will providean investor awareness and media exposure program intended to increasethe Company’s market visibility and broaden investor reach. Servicesinclude ongoing content distribution such as articles, newsletterfeatures, press release amplification and recap coverage acrossIBN’s media, syndication and social channels. The engagement alsoincludes promotional support through interviews, social mediarelations, and access to IBN’s partner network and consultingexperience. The promotional activity will occur through InvestorWire,InvestorNewsBreaks, IBN newsletters, IBN’s social media network,podcast directories including Apple Podcasts, Spotify and iHeartRadio,and broader syndication channels. IBN will receive cash compensationof $34,847.50 per quarter for a 12-month term, for aggregatecompensation of $139,390. No stock options or other securities-basedcompensation will be granted in connection with the engagement.</p>
<p>The IBN contact details are as follows:</p>
<p>Investor Brand Network</p>
<p>1108 Lavaca Street, Suite 110-IBN</p>
<p>Austin, TX 78701</p>
<p>Contact : Dutch DeWaard</p>
<p>Email: Dutch@IBN.fm</p>
<p>General Office Telephone: (512) 354-7000</p>
<p>Contact Telephone: 480-734-5834</p>
<p>For further information, please contact:</p>
<p>Justin Hanka, Chief ExecutiveOfficer</p>
<p>+61 433140886</p>
<p>justin@mindbiotherapeutics.com</p>
<p>www.mindbiotherapeutics.com</p>
<p>About MindBio TherapeuticsCorp.</p>
<p>MindBio is a biotechnologycompany that is commercialising AI prediction technologies for drugand alcohol intoxication detection via voice analysis. The AIprediction model uses over 50 million data points to predict alcoholintoxication with remarkable accuracy, just by using the human voice.The Company is now collecting data that will allow its prediction toolto work on other types of intoxication for use in consumer andenterprise environments.</p>
<div class="lb-trans"><p>MindBio 是一家生物技术公司，正在商业化用于通过声音分析检测药物和酒精中毒的人工智能预测技术。该人工智能预测模型利用超过 5000 万个数据点，仅通过人声就能以显著的准确性预测酒精中毒。公司目前正在收集数据，以使其预测工具能够在消费者和企业环境中用于其他类型的中毒检测。</p>
</div><p>Cautionary Note ConcerningForward-Looking Statements:</p>
<div class="lb-trans"><p>关于前瞻性声明的警示说明：</p>
</div><p>The press release contains “forward-lookingstatements” within the meaning of applicable securities laws,including but not limited to, statements regarding the intended use ofproceeds from the Offering, including the development of theCompany’s enterprise platform using voice and powered by AI for usein detecting drug and alcohol intoxication, and the expected duration,scope and anticipated benefits of the Company’s engagements with TheMarket Link and Investor Brand Network. Forward-looking statements canbe identified by words such as: “anticipate,” “intend,”“plan,” “budget,” “believe,” “project,”“estimate,” “expect,” “scheduled,”“forecast,” “strategy,” “future,” “likely,” “may,”“to be,” “could,” “would,” “should,” “will” andsimilar references to future periods or the negative or comparableterminology, as well as terms usually used in the future andconditional. Forward-looking statements are based on assumptions as ofthe date they are provided. However, there can be no assurance thatsuch assumptions will reflect the actual outcome of such items orfactors.</p>
<div class="lb-trans"><p>本新闻稿包含适用证券法意义上的 “前瞻性声明”，包括但不限于关于本次发行收益的预期用途的声明，包括使用声音和人工智能开发公司的企业平台以检测药物和酒精中毒，以及公司与市场链接和投资者品牌网络的合作的预期持续时间、范围和预期收益。前瞻性声明可以通过以下词语识别：“预期”、“打算”、“计划”、“预算”、“相信”、“项目”、“估计”、“期望”、“安排”、“预测”、“战略”、“未来”、“可能”、“可能会”、“将要”、“可以”、“会”、“应该”、“将” 和类似的对未来时期的引用或否定或可比术语，以及通常用于未来和条件的术语。前瞻性声明基于提供时的假设。然而，不能保证这些假设会反映这些项目或因素的实际结果。</p>
</div><p>Additionally, there are known and unknown risk factorsthat could cause the Company’s actual results and financialconditions to differ materially from those indicated in theforward-looking statements. Therefore, you should not rely on any ofthese forward-looking statements. Important risk factors that couldcause actual results and financial conditions to differ materiallyfrom those indicated in the forward-looking statements, include amongothers: the failure to obtain the final regulatory approval; technicalchallenges in the development or deployment of its enterpriseplatform; general economic, market and businessconditions in Canada and Australia; market volatility; and unforeseendelays in timelines for any of the transactions or events described inthis press release. All forward-looking information is qualified inits entirety by this cautionary statement.</p>
<div class="lb-trans"><p>此外，存在已知和未知的风险因素，可能导致公司的实际结果和财务状况与前瞻性声明中所指示的显著不同。因此，您不应依赖这些前瞻性声明。可能导致实际结果和财务状况与前瞻性声明中所指示的显著不同的重要风险因素包括但不限于：未能获得最终监管批准；企业平台开发或部署中的技术挑战；加拿大和澳大利亚的一般经济、市场和商业状况；市场波动；以及任何本新闻稿中描述的交易或事件的时间表中不可预见的延误。所有前瞻性信息均完全受此警示声明的限制。</p>
</div><p>The Company disclaims any obligation to revise orupdate any such forward-looking statement or to publicly announce theresult of any revisions to any of the forward-looking informationcontained herein to reflect future results, events or developments,except as required by law.</p>
<div class="lb-trans"><p>公司不承担修订或更新任何此类前瞻性声明的义务，也不承担公开宣布任何修订结果以反映未来结果、事件或发展的义务，除非法律要求。</p>
</div><p>Neither the Canadian Securities Exchange nor itsRegulation Service Provider (as that term is defined in the policiesof the Canadian Securities Exchange) accepts responsibility for theadequacy or accuracy of this release.</p>
<div class="lb-trans"><p>加拿大证券交易所及其监管服务提供者（根据加拿大证券交易所政策定义的术语）对本发布的充分性或准确性不承担任何责任。</p>
</div><p>Copyright (c) 2026 TheNewswire - All rights reserved.</p>
<div class="lb-trans"><p>版权 (c) 2026 TheNewswire - 保留所有权利。</p>
</div>

MindBio 宣布完成私募配售